Skip to main content
Erschienen in:

01.12.2022 | Pediatric Gastroenterology (SA Saeed and E Mezoff, Section Editors)

Pediatric Nausea—a Review of Current Management

verfasst von: Liane Sadder, MD, Rinarani Sanghavi, MD, MBA

Erschienen in: Current Treatment Options in Pediatrics | Ausgabe 4/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Nausea is a common symptom in children for a variety of reasons ranging from intestinal, extraintestinal, and functional. Defining it is challenging as some children may not be able to verbalize the symptoms and it is often associated with functional gastrointestinal disorders (FGIDs). The burden of nausea amongst children has been demonstrated by its association with anxiety, depression, and impaired school performance. This review will discuss the pathophysiology of childhood nausea along with established and new treatment options.

Recent Findings

By exploring the biopsychosocial model, namely the interplay between peripheral chemoreceptors, central neuronal pathways, and the environment, we can improve diagnosis and management. The diagnosis of nausea is mainly clinical and it is important to identify alarm symptoms, such as weight loss, bilious emesis, and neurologic symptoms, that would prompt further evaluation. There are numerous causes of nausea to consider, including both intestinal and extraintestinal pathologies. A detailed history and physical exam frequently help to narrow the diagnosis. The treatment options for nausea are expanding and include pharmacologic and non-pharmacologic therapies, but further research is imperative.

Summary

This review focuses on the current treatment opinions in the management of pediatric nausea based on the biopsychosocial model and focuses on newer therapies and includes non-pharmacological approaches to childhood nausea.
Literatur
1.
Zurück zum Zitat Hasler WL, Chey WD. Nausea and vomiting. Gastroenterology. 2003;125(6):1860–7.CrossRef Hasler WL, Chey WD. Nausea and vomiting. Gastroenterology. 2003;125(6):1860–7.CrossRef
2.
Zurück zum Zitat Saps M. High prevalence of nausea among school children in Latin America. J Pediatr. 2016;169:98–104.CrossRef Saps M. High prevalence of nausea among school children in Latin America. J Pediatr. 2016;169:98–104.CrossRef
3.
Zurück zum Zitat Kovacic K, et al. High prevalence of nausea in children with pain-associated functional gastrointestinal disorders: are Rome criteria applicable? J Pediatr Gastroenterol Nutr. 2013;57(3):311–5.CrossRef Kovacic K, et al. High prevalence of nausea in children with pain-associated functional gastrointestinal disorders: are Rome criteria applicable? J Pediatr Gastroenterol Nutr. 2013;57(3):311–5.CrossRef
4.
Zurück zum Zitat Chitkara DK, Rawat DJ, Talley NJ. The epidemiology of childhood recurrent abdominal pain in Western countries: a systematic review. Am J Gastroenterol. 2005;100(8):1868–75.CrossRef Chitkara DK, Rawat DJ, Talley NJ. The epidemiology of childhood recurrent abdominal pain in Western countries: a systematic review. Am J Gastroenterol. 2005;100(8):1868–75.CrossRef
5.
Zurück zum Zitat Russell A, Sherman AL, Walker LS. 620 nausea complicating recurrent abdominal pain in childhood predicts functional GI disorders, disability, depression and anxiety in young adulthood: results of a prospective cohort study. Gastroenterology. 2015;148(4):S-122.CrossRef Russell A, Sherman AL, Walker LS. 620 nausea complicating recurrent abdominal pain in childhood predicts functional GI disorders, disability, depression and anxiety in young adulthood: results of a prospective cohort study. Gastroenterology. 2015;148(4):S-122.CrossRef
6.
Zurück zum Zitat Hornby PJ. Central neurocircuitry associated with emesis. Am J Med. 2001;111 Suppl 8A(8):106S-112S.CrossRef Hornby PJ. Central neurocircuitry associated with emesis. Am J Med. 2001;111 Suppl 8A(8):106S-112S.CrossRef
7.
Zurück zum Zitat Kovacic K, Di Lorenzo C. Functional nausea in children. J Pediatr Gastroenterol Nutr. 2016;62(3):365–71.CrossRef Kovacic K, Di Lorenzo C. Functional nausea in children. J Pediatr Gastroenterol Nutr. 2016;62(3):365–71.CrossRef
8.
Zurück zum Zitat Kashyap P, Farrugia G. Diabetic gastroparesis: what we have learned and had to unlearn in the past 5 years. Gut. 2010;59(12):1716.CrossRef Kashyap P, Farrugia G. Diabetic gastroparesis: what we have learned and had to unlearn in the past 5 years. Gut. 2010;59(12):1716.CrossRef
9.
Zurück zum Zitat Pasricha PJ, et al. Characteristics of patients with chronic unexplained nausea and vomiting and normal gastric emptying. Clin Gastroenterol Hepatol. 2011;9(7):567-76.e1-4.CrossRef Pasricha PJ, et al. Characteristics of patients with chronic unexplained nausea and vomiting and normal gastric emptying. Clin Gastroenterol Hepatol. 2011;9(7):567-76.e1-4.CrossRef
10.
Zurück zum Zitat Chelimsky G, et al. Autonomic abnormalities in children with functional abdominal pain: coincidence or etiology? J Pediatr Gastroenterol Nutr. 2001;33(1):47–53.CrossRef Chelimsky G, et al. Autonomic abnormalities in children with functional abdominal pain: coincidence or etiology? J Pediatr Gastroenterol Nutr. 2001;33(1):47–53.CrossRef
11.
Zurück zum Zitat Lacount L, et al. Dynamic cardiovagal response to motion sickness: a point-process heart rate variability study. Comput Cardiol. 2009;36:49–52. Lacount L, et al. Dynamic cardiovagal response to motion sickness: a point-process heart rate variability study. Comput Cardiol. 2009;36:49–52.
12.
Zurück zum Zitat Kim YY, et al. Characteristic changes in the physiological components of cybersickness. Psychophysiology. 2005;42(5):616–25. Kim YY, et al. Characteristic changes in the physiological components of cybersickness. Psychophysiology. 2005;42(5):616–25.
13.
Zurück zum Zitat Koppen IJN, et al. The pediatric Rome IV criteria: what’s new? Expert Rev Gastroenterol Hepatol. 2017;11(3):1–9.CrossRef Koppen IJN, et al. The pediatric Rome IV criteria: what’s new? Expert Rev Gastroenterol Hepatol. 2017;11(3):1–9.CrossRef
14.
Zurück zum Zitat Gershon MD. 5-Hydroxytryptamine (serotonin) in the gastrointestinal tract. Curr Opin Endocrinol Diabetes Obes. 2013;20(1):14–21.CrossRef Gershon MD. 5-Hydroxytryptamine (serotonin) in the gastrointestinal tract. Curr Opin Endocrinol Diabetes Obes. 2013;20(1):14–21.CrossRef
15.
16.
Zurück zum Zitat Galligan JJ. Ligand-gated ion channels in the enteric nervous system. Neurogastroenterol Motil. 2002;14(6):611–23.CrossRef Galligan JJ. Ligand-gated ion channels in the enteric nervous system. Neurogastroenterol Motil. 2002;14(6):611–23.CrossRef
17.
Zurück zum Zitat Loewen PS, Marra CA, Zed PJ. 5-HT3 receptor antagonistsvs traditional agents for the prophylaxis of postoperative nausea and vomiting. Can J Anesth. 2000;47(10):1008–18.CrossRef Loewen PS, Marra CA, Zed PJ. 5-HT3 receptor antagonistsvs traditional agents for the prophylaxis of postoperative nausea and vomiting. Can J Anesth. 2000;47(10):1008–18.CrossRef
19.
Zurück zum Zitat Kovacic K, et al. Chronic idiopathic nausea of childhood. J Pediatr. 2014;164(5):1104–9.CrossRef Kovacic K, et al. Chronic idiopathic nausea of childhood. J Pediatr. 2014;164(5):1104–9.CrossRef
20.
Zurück zum Zitat Belkacemi L, Darmani NA. Dopamine receptors in emesis: molecular mechanisms and potential therapeutic function. Pharmacol Res. 2020;161:105124.CrossRef Belkacemi L, Darmani NA. Dopamine receptors in emesis: molecular mechanisms and potential therapeutic function. Pharmacol Res. 2020;161:105124.CrossRef
21.
Zurück zum Zitat Sanger GJ, Broad J, Andrews PLR. The relationship between gastric motility and nausea: gastric prokinetic agents as treatments. Eur J Pharmacol. 2013;715(1–3):10–4.CrossRef Sanger GJ, Broad J, Andrews PLR. The relationship between gastric motility and nausea: gastric prokinetic agents as treatments. Eur J Pharmacol. 2013;715(1–3):10–4.CrossRef
22.
Zurück zum Zitat Freedman SB, Fuchs S. Antiemetic therapy in pediatric emergency departments. Pediatr Emerg Care. 2004;20(9):625–33 (quiz 633-5).CrossRef Freedman SB, Fuchs S. Antiemetic therapy in pediatric emergency departments. Pediatr Emerg Care. 2004;20(9):625–33 (quiz 633-5).CrossRef
23.
Zurück zum Zitat Lau Moon Lin M, et al. The safety of metoclopramide in children: a systematic review and meta-analysis. Drug Saf. 2016;39(7):675–87.CrossRef Lau Moon Lin M, et al. The safety of metoclopramide in children: a systematic review and meta-analysis. Drug Saf. 2016;39(7):675–87.CrossRef
24.
Zurück zum Zitat Cristofori F, et al. Efficacy of the neurokinin-1 receptor antagonist aprepitant in children with cyclical vomiting syndrome. Aliment Pharmacol Ther. 2014;40(3):309–17.CrossRef Cristofori F, et al. Efficacy of the neurokinin-1 receptor antagonist aprepitant in children with cyclical vomiting syndrome. Aliment Pharmacol Ther. 2014;40(3):309–17.CrossRef
25.
Zurück zum Zitat Fahler J, Wall GC, Leman BI. Gastroparesis-associated refractory nausea treated with aprepitant. Ann Pharmacother. 2012;46(12):e38.CrossRef Fahler J, Wall GC, Leman BI. Gastroparesis-associated refractory nausea treated with aprepitant. Ann Pharmacother. 2012;46(12):e38.CrossRef
26.
Zurück zum Zitat Gupta K, Walton R, Kataria SP. Chemotherapy-induced nausea and vomiting: pathogenesis, recommendations, and new trends. Cancer Treat Res Commun. 2021;26:100278.CrossRef Gupta K, Walton R, Kataria SP. Chemotherapy-induced nausea and vomiting: pathogenesis, recommendations, and new trends. Cancer Treat Res Commun. 2021;26:100278.CrossRef
27.
Zurück zum Zitat Cangemi DJ, Kuo B. Practical perspectives in the treatment of nausea and vomiting. J Clin Gastroenterol. 2019;53(3):170–8. This article distinguishes between the pathophysiologies of acute and chronic nausea. It provides a comprehensive overview of the management of chronic nausea and vomiting, mainly in adults. There is a concise summary of the mechanisms, dosage, and side effects of current therapies used for nausea and vomiting.CrossRef Cangemi DJ, Kuo B. Practical perspectives in the treatment of nausea and vomiting. J Clin Gastroenterol. 2019;53(3):170–8. This article distinguishes between the pathophysiologies of acute and chronic nausea. It provides a comprehensive overview of the management of chronic nausea and vomiting, mainly in adults. There is a concise summary of the mechanisms, dosage, and side effects of current therapies used for nausea and vomiting.CrossRef
28.
Zurück zum Zitat • Arruda J, Yeh AM. Integrative approach to pediatric nausea. Pediatr Ann. 2019;48(6):e236–42. This article is one of few that outlines the emerging nonpharmacologic therapies for the management of pediatric nausea including mind-body modalities, botanicals and supplements, acupuncture, and aromatherapy. Each therapy is discussed along with a review of the study population, strength of evidence, side effects, and recommendations.CrossRef • Arruda J, Yeh AM. Integrative approach to pediatric nausea. Pediatr Ann. 2019;48(6):e236–42. This article is one of few that outlines the emerging nonpharmacologic therapies for the management of pediatric nausea including mind-body modalities, botanicals and supplements, acupuncture, and aromatherapy. Each therapy is discussed along with a review of the study population, strength of evidence, side effects, and recommendations.CrossRef
29.
Zurück zum Zitat Kovacic K, Sood M, Venkatesan T. Cyclic vomiting syndrome in children and adults: what is new in 2018? Curr Gastroenterol Rep. 2018;20(10):46.CrossRef Kovacic K, Sood M, Venkatesan T. Cyclic vomiting syndrome in children and adults: what is new in 2018? Curr Gastroenterol Rep. 2018;20(10):46.CrossRef
30.
Zurück zum Zitat Viljoen E, et al. A systematic review and meta-analysis of the effect and safety of ginger in the treatment of pregnancy-associated nausea and vomiting. Nutr J. 2014;13(20):20.CrossRef Viljoen E, et al. A systematic review and meta-analysis of the effect and safety of ginger in the treatment of pregnancy-associated nausea and vomiting. Nutr J. 2014;13(20):20.CrossRef
31.
Zurück zum Zitat Ernst E, Pittler MH. Efficacy of ginger for nausea and vomiting: a systematic review of randomized clinical trials. Br J Anaesth. 2000;84(3):367–71.CrossRef Ernst E, Pittler MH. Efficacy of ginger for nausea and vomiting: a systematic review of randomized clinical trials. Br J Anaesth. 2000;84(3):367–71.CrossRef
32.
Zurück zum Zitat Bossi P, et al. A randomized, double-blind, placebo-controlled, multicenter study of a ginger extract in the management of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high-dose cisplatin. Ann Oncol. 2017;28(10):2547–51.CrossRef Bossi P, et al. A randomized, double-blind, placebo-controlled, multicenter study of a ginger extract in the management of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high-dose cisplatin. Ann Oncol. 2017;28(10):2547–51.CrossRef
33.
Zurück zum Zitat Crichton M, et al. Efficacy of ginger (Zingiber officinale) in ameliorating chemotherapy-induced nausea and vomiting and chemotherapy-related outcomes: a systematic review update and meta-analysis. J Acad Nutr Diet. 2019;119(12):2055–68.CrossRef Crichton M, et al. Efficacy of ginger (Zingiber officinale) in ameliorating chemotherapy-induced nausea and vomiting and chemotherapy-related outcomes: a systematic review update and meta-analysis. J Acad Nutr Diet. 2019;119(12):2055–68.CrossRef
34.
Zurück zum Zitat Kline RM, et al. Enteric-coated, pH-dependent peppermint oil capsules for the treatment of irritable bowel syndrome in children. J Pediatr. 2001;138(1):125–8.CrossRef Kline RM, et al. Enteric-coated, pH-dependent peppermint oil capsules for the treatment of irritable bowel syndrome in children. J Pediatr. 2001;138(1):125–8.CrossRef
35.
Zurück zum Zitat Chumpitazi BP, Kearns GL, Shulman RJ. Review article: the physiological effects and safety of peppermint oil and its efficacy in irritable bowel syndrome and other functional disorders. Aliment Pharmacol Ther. 2018;47(6):738–52.CrossRef Chumpitazi BP, Kearns GL, Shulman RJ. Review article: the physiological effects and safety of peppermint oil and its efficacy in irritable bowel syndrome and other functional disorders. Aliment Pharmacol Ther. 2018;47(6):738–52.CrossRef
36.
Zurück zum Zitat Mapp CP, et al. Peppermint oil: evaluating efficacy on nausea in patients receiving chemotherapy in the ambulatory setting. Clin J Oncol Nurs. 2020;24(2):160–4.CrossRef Mapp CP, et al. Peppermint oil: evaluating efficacy on nausea in patients receiving chemotherapy in the ambulatory setting. Clin J Oncol Nurs. 2020;24(2):160–4.CrossRef
37.
Zurück zum Zitat McParlin C, et al. Treatments for hyperemesis gravidarum and nausea and vomiting in pregnancy: a systematic review. JAMA. 2016;316(13):1392–401.CrossRef McParlin C, et al. Treatments for hyperemesis gravidarum and nausea and vomiting in pregnancy: a systematic review. JAMA. 2016;316(13):1392–401.CrossRef
38.
Zurück zum Zitat von Arnim U, et al. STW 5, a phytopharmacon for patients with functional dyspepsia: results of a multicenter, placebo-controlled double-blind study. Am J Gastroenterol. 2007;102(6):1268–75.CrossRef von Arnim U, et al. STW 5, a phytopharmacon for patients with functional dyspepsia: results of a multicenter, placebo-controlled double-blind study. Am J Gastroenterol. 2007;102(6):1268–75.CrossRef
39.
Zurück zum Zitat Ottillinger B, et al. STW 5 (Iberogast®)—a safe and effective standard in the treatment of functional gastrointestinal disorders. Wiener Med Wochenschr (1946). 2013;163(3–4):65–72.CrossRef Ottillinger B, et al. STW 5 (Iberogast®)—a safe and effective standard in the treatment of functional gastrointestinal disorders. Wiener Med Wochenschr (1946). 2013;163(3–4):65–72.CrossRef
40.
Zurück zum Zitat Morehead A, Salmon G. Efficacy of acupuncture/acupressure in the prevention and treatment of nausea and vomiting across multiple patient populations. Nurs Clin N Am. 2020;55:571–80.CrossRef Morehead A, Salmon G. Efficacy of acupuncture/acupressure in the prevention and treatment of nausea and vomiting across multiple patient populations. Nurs Clin N Am. 2020;55:571–80.CrossRef
41.
Zurück zum Zitat Lee A, Chan SK, Fan LT. Stimulation of the wrist acupuncture point PC6 for preventing postoperative nausea and vomiting. Cochrane Database Syst Rev. 2015;2016(11):CD003281. Lee A, Chan SK, Fan LT. Stimulation of the wrist acupuncture point PC6 for preventing postoperative nausea and vomiting. Cochrane Database Syst Rev. 2015;2016(11):CD003281.
42.
Zurück zum Zitat Richardson J, et al. Hypnosis for nausea and vomiting in cancer chemotherapy: a systematic review of the research evidence. Eur J Cancer Care (Engl). 2007;16(5):402–12.CrossRef Richardson J, et al. Hypnosis for nausea and vomiting in cancer chemotherapy: a systematic review of the research evidence. Eur J Cancer Care (Engl). 2007;16(5):402–12.CrossRef
43.
Zurück zum Zitat Haug TT, Mykletun A, Dahl AA. The prevalence of nausea in the community: psychological, social and somatic factors. Gen Hosp Psychiatry. 2002;24(2):81–6.CrossRef Haug TT, Mykletun A, Dahl AA. The prevalence of nausea in the community: psychological, social and somatic factors. Gen Hosp Psychiatry. 2002;24(2):81–6.CrossRef
44.
Zurück zum Zitat Palsson OS, Ballou S. Hypnosis and cognitive behavioral therapies for the management of gastrointestinal disorders. Curr Gastroenterol Rep. 2020;22(7):31.CrossRef Palsson OS, Ballou S. Hypnosis and cognitive behavioral therapies for the management of gastrointestinal disorders. Curr Gastroenterol Rep. 2020;22(7):31.CrossRef
45.
Zurück zum Zitat Lembo A, et al. Relamorelin reduces vomiting frequency and severity and accelerates gastric emptying in adults with diabetic gastroparesis. Gastroenterology. 2016;151(1):87-96.e6.CrossRef Lembo A, et al. Relamorelin reduces vomiting frequency and severity and accelerates gastric emptying in adults with diabetic gastroparesis. Gastroenterology. 2016;151(1):87-96.e6.CrossRef
46.
Zurück zum Zitat Parkman HP, Carlson MR, Gonyer D. Metoclopramide nasal spray is effective in symptoms of gastroparesis in diabetics compared to conventional oral tablet. Neurogastroenterol Motil. 2014;26(4):521–8.CrossRef Parkman HP, Carlson MR, Gonyer D. Metoclopramide nasal spray is effective in symptoms of gastroparesis in diabetics compared to conventional oral tablet. Neurogastroenterol Motil. 2014;26(4):521–8.CrossRef
47.
Zurück zum Zitat Teich S, et al. Efficacy of permanent gastric electrical stimulation for the treatment of gastroparesis and functional dyspepsia in children and adolescents. J Pediatr Surg. 2013;48(1):178–83.CrossRef Teich S, et al. Efficacy of permanent gastric electrical stimulation for the treatment of gastroparesis and functional dyspepsia in children and adolescents. J Pediatr Surg. 2013;48(1):178–83.CrossRef
48.
Zurück zum Zitat Lu PL, Di Lorenzo C. Neurostimulation of the gastrointestinal tract in children: is it time to shock the gut? Curr Opin Pediatr. 2016;28(5):631–7.CrossRef Lu PL, Di Lorenzo C. Neurostimulation of the gastrointestinal tract in children: is it time to shock the gut? Curr Opin Pediatr. 2016;28(5):631–7.CrossRef
49.
Zurück zum Zitat Babygirija R, et al. Percutaneous electrical nerve field stimulation modulates central pain pathways and attenuates post-inflammatory visceral and somatic hyperalgesia in rats. Neuroscience. 2017;356:11–21.CrossRef Babygirija R, et al. Percutaneous electrical nerve field stimulation modulates central pain pathways and attenuates post-inflammatory visceral and somatic hyperalgesia in rats. Neuroscience. 2017;356:11–21.CrossRef
50.
Zurück zum Zitat • Krasaelap A, et al. Efficacy of auricular neurostimulation in adolescents with irritable bowel syndrome in a randomized, double-blind trial. Clin Gastroenterol Hepatol. 2020;18(9):1987-1994.e2. This randomized controlled trial assessed the impact of auricular neurostimulation on the severity of abdominal pain amongst patients with irritable bowel syndrome. The results demonstrated a significant improvement in abdominal pain severity among patients who received percutaneous electrical nerve field stimulation to the external ear as compared with those who received sham stimulation. This was a promising outcome for FGIDs, prompting a subsequent, pending trial in children with cyclic vomiting syndrome.CrossRef • Krasaelap A, et al. Efficacy of auricular neurostimulation in adolescents with irritable bowel syndrome in a randomized, double-blind trial. Clin Gastroenterol Hepatol. 2020;18(9):1987-1994.e2. This randomized controlled trial assessed the impact of auricular neurostimulation on the severity of abdominal pain amongst patients with irritable bowel syndrome. The results demonstrated a significant improvement in abdominal pain severity among patients who received percutaneous electrical nerve field stimulation to the external ear as compared with those who received sham stimulation. This was a promising outcome for FGIDs, prompting a subsequent, pending trial in children with cyclic vomiting syndrome.CrossRef
51.
Zurück zum Zitat Kovacic K, et al. Neurostimulation for abdominal pain-related functional gastrointestinal disorders in adolescents: a randomised, double-blind, sham-controlled trial. Lancet Gastroenterol Hepatol. 2017;2(10):727–37.CrossRef Kovacic K, et al. Neurostimulation for abdominal pain-related functional gastrointestinal disorders in adolescents: a randomised, double-blind, sham-controlled trial. Lancet Gastroenterol Hepatol. 2017;2(10):727–37.CrossRef
Metadaten
Titel
Pediatric Nausea—a Review of Current Management
verfasst von
Liane Sadder, MD
Rinarani Sanghavi, MD, MBA
Publikationsdatum
01.12.2022
Verlag
Springer International Publishing
Erschienen in
Current Treatment Options in Pediatrics / Ausgabe 4/2022
Elektronische ISSN: 2198-6088
DOI
https://doi.org/10.1007/s40746-022-00254-x

Weitere Artikel der Ausgabe 4/2022

Optimization of Pediatric Antibiotic Dosing Through Therapeutic Drug Monitoring

  • Pediatric Infectious Disease (M Mitchell and F Zhu, Section Editors)

Poor Weight Gain

  • Pediatric Gastroenterology (SA Saeed and E Mezoff, Section Editors)

Pediatric Overactive Bladder and the Role of Sacral Neuromodulation

  • Pediatric Urology (BA VanderBrink and RP Pramod, Section Editors)

Cardiac Arrest in Pediatric Cardiac ICUs: Prevention Comes First

  • Cardiology/CT Surgery (K Gist, Section Editor)

Kompaktes Leitlinien-Wissen Pädiatrie (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Pädiatrie

Weniger Bargeld, weniger Erstickungsnotfälle?

Dadurch, dass immer seltener mit Bargeld gezahlt wird, könnte die Rate an Erstickungsnotfällen bei Kindern zurückgehen. Dieser Hypothese ist ein britisches Forschungsteam in Klinikdaten aus den letzten zweieinhalb Jahrzehnten nachgegangen.

Pneumonie ausschließen: Auf das Röntgenbild ist offenbar Verlass

Das Thoraxröntgen ist gemäß Daten aus den USA eine zuverlässige Methode, um bei Kindern in der Notaufnahme rasch eine Lungenentzündung auszuschließen. Zur Vorsicht rät das Ärzteteam jedoch bei bestimmten klinischen Symptomen.

Kawasaki-Syndrom: Kein ASS mehr in der Akutphase?

Um Kinder mit Kawasaki-Syndrom vor entzündlich bedingten Veränderungen der Koronarien zu bewahren, werden sie in der Akutphase mit intravenösen Immunglobulinen und hochdosierter Acetylsalicylsäure (ASS) behandelt. Neuesten Daten zufolge könnte womöglich auf ASS verzichtet werden.

Neurologische Entwicklung von Kindern: Welchen Einfluss hat Stillen?

Stillen bringt zahlreiche gesundheitliche Vorteile mit sich. Ob dazu auch ein niedrigeres Risiko für Entwicklungsverzögerungen und -störungen gehört, hat nun eine israelische Studie untersucht.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.